Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

IMPACT IN ACTION: Cure Brain Cancer Foundation Launches Inaugural 5-Year Guardian Trust Early Career Fellowship valued at $575,000

SYDNEY, April 8, 2024 /PRNewswire/ -- In a historic first, Cure Brain Cancer Foundation proudly unveiled the launch of its groundbreaking 5-Year Guardian Trust Early Career Fellowship, valued at$575,000. The Guardian Trust Early Career Fellowship represents a bold commitment to fostering a new g...

2024-04-08 07:00 1164

Antengene Presents Four Preclinical Posters at AACR 2024

SHANGHAI and HONG KONG, April 6, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for canc...

2024-04-06 08:30 3020

OPTIC 2000 & AUSTRALIEGAD LAUNCHED AN ORIGINAL CHALLENGE AT THE GAMERS ASSEMBLY TO RAISE PUBLIC AWARENESS OF VISUAL IMPAIRMENT

PARIS, April 6, 2024 /PRNewswire/ -- At the Gamers Assembly in Poitiers, France , Optic 2000 & AUSTRALIEGAD set the best video game players an ambitious challenge: to take on a blind player, equipped with an innovative device, in one of the most legendary games. It was an inspiring experience, des...

2024-04-06 00:35 2511

HSA approves new asthma indication for GSK's Trelegy Ellipta, the first once-daily single inhaler triple therapy approved for use in the treatment of both asthma and COPD in Singapore

SINGAPORE, April 5, 2024 /PRNewswire/ -- GSK Singapore announced that the Health Sciences Authority (HSA) has approved a new indication and a new strength for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol 'FF/UMEC/VI') for the maintenance treatment of asthma in patients aged 18 yea...

2024-04-05 16:00 2675

HSA approves new asthma indication for GSK's Trelegy Ellipta, the first once-daily single inhaler triple therapy approved for use in the treatment of both asthma and COPD in Singapore

LBB Specialties Announces Principal Partnership with VIZOR

NORWALK, Conn., April 4, 2024 /PRNewswire/ -- LBB Specialties (LBBS), a leader inspecialty chemicals and ingredient distribution in North America, announces a new partnership with VIZOR®, a global leader in Zinc Oxide Powders and Dispersions. LBB Specialties will be VIZOR's exclusive channel part...

2024-04-04 21:01 1797

IRBM to Disclose Strong Antitumor Efficacy of Novel Preclinical Agents Against Aggressive Brain Tumors and Acute Lymphoblastic Leukemia at AACR

ROME, April 4, 2024 /PRNewswire/ -- IRBM, a leader in the field of drug discovery, announced today that it will be disclosing new data on two of its most promising internal assets at the upcoming American Association for Cancer Research (AACR) Annual Meeting occurring inSan Diego, April 5-10. The...

2024-04-04 21:00 2553

Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market

ZEISS secures regulatory approvals to acquire D.O.R.C.; companies now shift focus to integration implementation, fueling world-class innovation, and driving market expansion strategy for ophthalmic medical devices and surgery. JENA, Germany and DUBLIN, Calif., April 4, 2024 /PRNewswire/ -- Carl...

2024-04-04 19:00 3596

Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market

NEXTCHEM (MAIRE) TO COMBINE ITS PROPRIETARY GREEN AMMONIA TECHNOLOGY WITH VALLOUREC'S HYDROGEN STORAGE SYSTEM TO OFFER AN INTEGRATED SOLUTION FOR "POWER-TO-X" PROJECTS

* Upon completion of joint feasibility studies, NextChem Tech will act as the exclusive global licensor of the integrated technology package combining NEXTCHEM's small-scale green ammonia production technology with Vallourec's hydrogen storage system MILAN, April 4, 2024 /PRNewswire/ -- MAIRE a...

2024-04-04 18:44 2462

Human Frontier Science Program: Fellowships Awarded to 59 of the Most Pioneering Postdoctoral Scientists from 28 Nations

STRASBOURG, France, April 4, 2024 /PRNewswire/ -- To foster the next generation of life science research, 59 of the world's top emerging scientists from 28 nations have won 2024 Human Frontier Science Program (HFSP) Fellowships. "Brilliance is not born, it has to be cultivated," said HFSP Chief S...

2024-04-04 17:00 2372

SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership

The companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland, April 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced a s...

2024-04-04 13:00 1854

MEDLEY Opens Philippines Office to Support Global Growth

MANILA, Philippines, April 4, 2024 /PRNewswire/ -- Medley, Inc. (TSE: 4480) ("MEDLEY"), aJapan-based internet service company, opened its Philippine office in Bonifacio Global City (BGC), Taguig onApril 1st to support continued global growth. The opening of the new office and upcoming operation l...

2024-04-04 10:59 2878

MEDLEY Opens Philippines Office to Support Global Growth

iSono Health Applauded by Frost & Sullivan for Ensuring Patient Comfort and Safety and Providing Quality Imaging and Diagnosis with its iSono Health ATUSA

iSono Health AI ABUS ATUSA enables precise and prompt screening, eliminates delays and the need for trained technicians, provides cost-effective imaging, and improves patient outcomes significantly. SAN ANTONIO, April 3, 2024 /PRNewswire/ -- Recently, Frost & Sullivan assessed the breast ultraso...

2024-04-04 01:00 1783

iSono Health Applauded by Frost & Sullivan for Ensuring Patient Comfort and Safety and Providing Quality Imaging and Diagnosis with its iSono Health ATUSA

Jinxin Fertility and Morula Announce Strategic Cooperation in Southeast Asia

CHENGDU, China, April 3, 2024 /PRNewswire/ -- On April 1, 2024, Jinxin Fertility Group Limited ("JXR") and PT Morula Indonesia ("Morula") are pleased to announce a strategic cooperation between both parties, following the execution of investment share subscription and purchase agreement, whereby ...

2024-04-03 21:46 1817

YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility

GAITHERSBURG, Md., April 3, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2024-04-03 20:00 1534

Ascend to increase prices on nylon polymers, compounds

HOUSTON, April 3, 2024 /PRNewswire/ -- Ascend Performance Materials, the largest fully integrated producer of nylon 6,6, announced a new round of global price increases on its polyamide polymers and compounds, where contracts allow, as follows: Material Price Increase Neat PA66 polymer $0.30...

2024-04-03 19:00 1510

Health Justice Australia welcomes Sheree Limbrick as new CEO

SYDNEY, April 3, 2024 /PRNewswire/ -- Health Justice Australia has announced the appointment of Sheree Limbrick as their new CEO. She will replace founding CEO DrTessa Boyd-Caine. Ms Limbrick brings extensive experience in senior executive and governance positions across social and community ser...

2024-04-03 18:11 1637

Tianlong Participated in International Medical Congress of SCO Countries in Kyrgyzstan

BISHKEK, Kyrgyzstan, April 3, 2024 /PRNewswire/ -- The International Medical Congress of the SCO countries was held on 27-29 March inBishkek, Kyrgyzstan, under the theme "Innovations and technologies in the development of cardiology and non-communicable diseases in the countries of the Shanghai C...

2024-04-03 16:16 2042

Tianlong Participated in International Medical Congress of SCO Countries in Kyrgyzstan

Human Frontier Science Program: Research Grants Awarded to 108 of the Most Pioneering Life Scientists from 23 Nations

STRASBOURG, France, April 3, 2024 /PRNewswire/ -- Representing only the most daring and truly pioneering life science research, 108 of the world's top scientists from 23 nations have won 2024 Human Frontier Science Program (HFSP) Research Grants. "Excellence isn't enough for us – we support rese...

2024-04-03 15:00 1382

Great Place To Work unveils Top 10 Best Workplaces in Singapore Healthcare and Biopharma™ 2024

SINGAPORE, April 3, 2024 /PRNewswire/ -- Great Place To Work®, the global authority on workplace culture announcedSingapore's top 10 Best Workplaces in Healthcare and Biopharma™ in 2024.

2024-04-03 12:00 1988

RemeGen's Telitacicept (RC18) Granted Fast Track Designation by United States FDA for Treatment of Primary Sjögren's Syndrome

YANTAI, China, April 3, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, obtained Fast Track Designation (FTD) by the United States Food and Drug Administration (FDA) recently for its inno...

2024-04-03 11:14 1512

1 234 5 6 ... 552